To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Beginning fall 2026, students ...
A close-up of Keanu Reeves as Neo looking to the distance with sunglasses on in The Matrix. Image via Warner Bros. 1999’s The Matrix was a landmark in cinema, establishing an exciting new filmmaking ...
Rowan University and Holy Name Medical Center’s Claire Tynan School of Nursing are launching a dual-enrollment partnership. The initiative allows nursing students to take university courses online ...
Kyowa Kirin has decided to discontinue all clinical development of its OX40 drug after two new cancer cases emerged. Sanofi is committing up to $1.5 billion for global rights to Sino Biopharm's ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...
A new partnership between Delta Air Lines, Clayton County Public Schools, and Middle Georgia State University is giving local high school students a direct runway to aviation careers. Delta announced ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Delta Air Lines is making an ...
Evie Carrick is a writer and editor who’s lived in five countries and visited well over 50. She now splits her time between Colorado and Paris, ensuring she doesn't have to live without skiing or L'As ...
Matrix Midwest is the Heartland’s only free and independent sports network, available over-the-air on channel 9.2. Catch select St. Louis Cardinals, Kansas City Royals, and St. Louis Blues games. And ...
Novo Nordisk is hitting the gas on amycretin development. After posting phase 2 data, the company has decided to run pivotal diabetes trials of an asset that it previously saw primarily as an obesity ...